Our measurements demonstrated a trend toward elevated plasma GFAP within the concussion cohort (median 0.6 ng/ml; IQR 23.1; n = 11), when compared to their matched healthy control subjects (median 0.0 ng/ml, IQR 6.2; n = 17; P = 0.072). This evidence concerns the gene GFAP and brain injury.